Cellular Responses to Mild Heat Stress

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2004 Dec 25

PMID 15619003

Citations 56

Authors

H G Park

S I Han

S Y Oh

H S Kang

Affiliations

Soon will be listed here.

Abstract

Since its discovery in 1962 by Ritossa, the heat shock response has been extensively studied by a number of investigators to understand the molecular mechanism underlying the cellular response to heat stress. The most well characterized heat shock response is induction of the heat shock proteins that function as molecular chaperones and exert cell cycle regulatory and anti-apoptotic activities. While most investigators have focused their studies on the toxic effects of heat stress in organisms such as severe heat stress-induced cell cycle arrest and apoptosis, the cellular response to fever-ranged mild heat stress has been rather underestimated. However, the cellular response to mild heat stress is likely to be more important in a physiological sense than that to severe heat stress because the body temperature of homeothermic animals increases by only 1-2 degrees C during febrile diseases. Here we provide information that mild heat stress does have some beneficial role in organisms via positively regulating cell proliferation and differentiation, and immune response in mammalian cells.

Citing Articles

Rumen-protected guanidinoacetic acid improves growth performance in beef cattle under chronic heat stress by reshaping gut microbiota and modulating serum metabolism.

Geng Q, Lin W, Yang L, Hu X, Qiu X Front Microbiol. 2025; 16:1529596.

PMID: 40041874 PMC: 11877906. DOI: 10.3389/fmicb.2025.1529596.

Diet Impacts on Gene Expression in Healthy Colon Tissue: Insights from the BarcUVa-Seq Study.

Obon-Santacana M, Moratalla-Navarro F, Guino E, Carreras-Torres R, Diez-Obrero V, Bars-Cortina D Nutrients. 2024; 16(18).

PMID: 39339731 PMC: 11434945. DOI: 10.3390/nu16183131.

Thermal Stress and Nuclear Transport.

Kose S, Ogawa Y, Imamoto N Adv Exp Med Biol. 2024; 1461:61-78.

PMID: 39289274 DOI: 10.1007/978-981-97-4584-5_5.

Multi-species genome-wide CRISPR screens identify conserved suppressors of cold-induced cell death.

Lam B, Kajderowicz K, Keys H, Roessler J, Frenkel E, Kirkland A bioRxiv. 2024; .

PMID: 39091747 PMC: 11291167. DOI: 10.1101/2024.07.25.605098.

Effect of elevated temperature and hydrocortisone addition on the proliferation of fibroblasts.

Pavlikova Z, Zahradnicek O, Jelinek Michaelidesova A, Sramek J, Davidkova M, Hovorakova M Histochem Cell Biol. 2024; 162(3):231-244.

PMID: 38801536 PMC: 11322275. DOI: 10.1007/s00418-024-02295-9.

References

Jung C, Lauten A, Ferrari M . Microcirculation in cardiogenic shock: from scientific bystander to therapy target. Crit Care. 2010; 14(5):193. PMC: 3219249. DOI: 10.1186/cc9244. View

den Uil C, Lagrand W, van der Ent M, Jewbali L, Brugts J, Spronk P . The effects of intra-aortic balloon pump support on macrocirculation and tissue microcirculation in patients with cardiogenic shock. Cardiology. 2009; 114(1):42-6. DOI: 10.1159/000212060. View

Thiele H, Schuler G . Cardiogenic shock: to pump or not to pump?. Eur Heart J. 2009; 30(4):389-90. DOI: 10.1093/eurheartj/ehp030. View

Alfonso F, Collet J, Cremer J, Falk V, Filippatos G, Hamm C . 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special.... Eur J Cardiothorac Surg. 2014; 46(4):517-92. DOI: 10.1093/ejcts/ezu366. View

Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R . A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52(19):1584-8. DOI: 10.1016/j.jacc.2008.05.065. View

Jung C, Rodiger C, Fritzenwanger M, Schumm J, Lauten A, Figulla H . Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock. Clin Res Cardiol. 2009; 98(8):469-75. DOI: 10.1007/s00392-009-0018-0. View

Cheng J, den Uil C, Hoeks S, van der Ent M, Jewbali L, van Domburg R . Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009; 30(17):2102-8. DOI: 10.1093/eurheartj/ehp292. View

Thiele H, Sick P, Boudriot E, Diederich K, Hambrecht R, Niebauer J . Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005; 26(13):1276-83. DOI: 10.1093/eurheartj/ehi161. View

den Uil C, Lagrand W, van der Ent M, Jewbali L, Cheng J, Spronk P . Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2010; 31(24):3032-9. DOI: 10.1093/eurheartj/ehq324. View

10.

Thiele H, Schuler G, Neumann F, Hausleiter J, Olbrich H, Schwarz B . Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J. 2012; 163(6):938-45. DOI: 10.1016/j.ahj.2012.03.012. View

11.

Goldberg R, Spencer F, Gore J, Lessard D, Yarzebski J . Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009; 119(9):1211-9. PMC: 2730832. DOI: 10.1161/CIRCULATIONAHA.108.814947. View

12.

Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter J . Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2009; 38(1):152-60. DOI: 10.1097/CCM.0b013e3181b78671. View

13.

OGara P, Kushner F, Ascheim D, Casey Jr D, Chung M, de Lemos J . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012; 127(4):529-55. DOI: 10.1161/CIR.0b013e3182742c84. View

14.

Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J . Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013; 382(9905):1638-45. DOI: 10.1016/S0140-6736(13)61783-3. View

15.

Munsterman L, Elbers P, Ozdemir A, van Dongen E, van Iterson M, Ince C . Withdrawing intra-aortic balloon pump support paradoxically improves microvascular flow. Crit Care. 2010; 14(4):R161. PMC: 2945145. DOI: 10.1186/cc9242. View

16.

Altayyar S, Rochwerg B, Alnasser S, Al-Omari A, Baw B, Fox-Robichaud A . Intra-aortic balloon pump in patients with cardiogenic shock complicating myocardial infarction: a systematic review and meta-analysis of randomized trials (protocol). Syst Rev. 2014; 3:24. PMC: 4008254. DOI: 10.1186/2046-4053-3-24. View

17.

Nguyen H, Rivers E, Knoblich B, Jacobsen G, Muzzin A, Ressler J . Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004; 32(8):1637-42. DOI: 10.1097/01.ccm.0000132904.35713.a7. View

18.

Kern M, Aguirre F, Bach R, Donohue T, Siegel R, Segal J . Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation. 1993; 87(2):500-11. DOI: 10.1161/01.cir.87.2.500. View

19.

Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J . Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367(14):1287-96. DOI: 10.1056/NEJMoa1208410. View

20.

Burkhoff D, Cohen H, Brunckhorst C, ONeill W . A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006; 152(3):469.e1-8. DOI: 10.1016/j.ahj.2006.05.031. View